These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 34696688)
41. In silico Analysis and Molecular Docking Studies of Novel 4-Amino-3- (Isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]Pyrimidine Derivatives as Dual PI3-K/mTOR Inhibitors. Panchal II; Badeliya SN; Patel R; Patel A; Devaligar A Curr Drug Discov Technol; 2019; 16(3):297-306. PubMed ID: 30387396 [TBL] [Abstract][Full Text] [Related]
42. SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. Voelkl J; Luong TT; Tuffaha R; Musculus K; Auer T; Lian X; Daniel C; Zickler D; Boehme B; Sacherer M; Metzler B; Kuhl D; Gollasch M; Amann K; Müller DN; Pieske B; Lang F; Alesutan I J Clin Invest; 2018 Jul; 128(7):3024-3040. PubMed ID: 29889103 [TBL] [Abstract][Full Text] [Related]
43. Role of SGK1 in the Osteogenic Transdifferentiation and Calcification of Vascular Smooth Muscle Cells Promoted by Hyperglycemic Conditions. Poetsch F; Henze LA; Estepa M; Moser B; Pieske B; Lang F; Eckardt KU; Alesutan I; Voelkl J Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003561 [TBL] [Abstract][Full Text] [Related]
44. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations. Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832 [TBL] [Abstract][Full Text] [Related]
45. Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors. Halland N; Schmidt F; Weiss T; Saas J; Li Z; Czech J; Dreyer M; Hofmeister A; Mertsch K; Dietz U; Strübing C; Nazare M ACS Med Chem Lett; 2015 Jan; 6(1):73-8. PubMed ID: 25589934 [TBL] [Abstract][Full Text] [Related]
46. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19. Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and biological activity of 4-(imidazo[1,2-b]pyridazin-3-yl)-1H-pyrazol-1-yl-phenylbenzamide derivatives as BCR-ABL kinase inhibitors. Hu L; Cao T; Lv Y; Ding Y; Yang L; Zhang Q; Guo M Bioorg Med Chem Lett; 2016 Dec; 26(23):5830-5835. PubMed ID: 28029512 [TBL] [Abstract][Full Text] [Related]
50. Inhibition potential evaluation of two synthetic bis-indole compounds on amyloid fibrillation: a molecular simulation study. Khodayari K; Alipour M; Rad I; Ramshini H; Abdolmaleki P J Biomol Struct Dyn; 2022 Jun; 40(9):4051-4061. PubMed ID: 34043939 [TBL] [Abstract][Full Text] [Related]
51. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973 [TBL] [Abstract][Full Text] [Related]
52. Molecular docking and molecular dynamics studies of bioactive compounds contained in noni fruit ( Lolok N; Sumiwi SA; Muhtadi A; Susilawati Y; Hendriani R; Ramadhan DSF; Levita J; Sahidin I J Biomol Struct Dyn; 2022 Sep; 40(15):7091-7098. PubMed ID: 33682637 [TBL] [Abstract][Full Text] [Related]
53. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Kobayashi T; Deak M; Morrice N; Cohen P Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550 [TBL] [Abstract][Full Text] [Related]
55. Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors. Sommer EM; Dry H; Cross D; Guichard S; Davies BR; Alessi DR Biochem J; 2013 Jun; 452(3):499-508. PubMed ID: 23581296 [TBL] [Abstract][Full Text] [Related]
56. Molecular docking and molecular dynamics simulation of Oyewusi HA; Huyop F; Wahab RA J Biomol Struct Dyn; 2022 Mar; 40(5):1979-1994. PubMed ID: 33094694 [TBL] [Abstract][Full Text] [Related]
57. Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies. Snoussi M; Redissi A; Mosbah A; De Feo V; Adnan M; Aouadi K; Alreshidi M; Patel M; Kadri A; Noumi E J Biomol Struct Dyn; 2022; 40(20):10122-10135. PubMed ID: 34254564 [TBL] [Abstract][Full Text] [Related]
58. Role of serum- and glucocorticoid-inducible kinases in stroke. Inoue K; Leng T; Yang T; Zeng Z; Ueki T; Xiong ZG J Neurochem; 2016 Jul; 138(2):354-61. PubMed ID: 27123541 [TBL] [Abstract][Full Text] [Related]
59. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1. Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564 [TBL] [Abstract][Full Text] [Related]
60. Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release. Reiter MH; Vila G; Knosp E; Baumgartner-Parzer SM; Wagner L; Stalla GK; Luger A Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E336-41. PubMed ID: 21586695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]